LEADER 02237nam  2200421   450 
001 9910583033403321
005 20230120002517.0
010   $a0-12-805266-X
035   $a(CKB)3710000001140428
035   $a(MiAaPQ)EBC4834795
035   $a(EXLCZ)993710000001140428
100   $a20170419h20172017  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aDisease-modifying targets in neurodegenerative disorders $epaving the way for disease-modifying therapies /$fedited by Veerle Baekelandt, Evy Lobbestael
210  1$aLondon, [England] :$cAcademic Press,$d2017.
210  4$dİ2017
215   $a1 online resource (320 pages) $cillustrations
300   $aIncludes index.
311   $a0-12-805120-5 
327   $aThe multitude of therapeutic targets in neurodegenerative proteinopathies / R. Melki -- Synuclein misfolding as a therapeuic target / W. Peelarts, T.F. Outeiro -- Neuroinflammation as a therapeutic target in neurodegenerative diseases / R. Gordon, T.M. Woodruff -- Stem cells in neurodegeneration / C. Claes, J. Terryn, C.M. Verfaillie -- The potential of stem cells in tackling neurodegenerative dieases / S. Libbrecht -- Preclinical models of alzheimer's disease for identification and preclinical validation of therapeutic targets / B. Vasconcelos, M. Bird, I.-C. Stancu, D. Terwel, I. Dewachter -- Parkinson's disease / M.R. Cookson -- Lewy body dementia / M. Delenclos, S. Moussaud, P.J. McLean -- Frontotemporal dementia / E. Wauters, K. Sleegers, M. Cruts, C. Van Broekhaven -- From huntington gene to huntington's disease-altering strategies / N. De?glon -- Amyotrophic lateral sclerosis / L. Van Den Bosch.
606   $aNervous system$xDiseases$xTreatment
606   $aNervous system$xDegeneration
615  0$aNervous system$xDiseases$xTreatment.
615  0$aNervous system$xDegeneration.
676   $a616.8046
702   $aBaekelandt$b Veerle
702   $aLobbestael$b Evy
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583033403321
996   $aDisease-modifying targets in neurodegenerative disorders$92173283
997   $aUNINA